India · Delayed Price · Currency is INR Remus Pharmaceuticals Statistics
Total Valuation
NSE:REMUS has a market cap or net worth of INR 9.47 billion. The enterprise value is 9.59 billion.
| Market Cap | 9.47B |
| Enterprise Value | 9.59B |
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Nov 6, 2026 |
Share Statistics
NSE:REMUS has 11.78 million shares outstanding. The number of shares has decreased by -0.27% in one year.
| Current Share Class | 11.78M |
| Shares Outstanding | 11.78M |
| Shares Change (YoY) | -0.27% |
| Shares Change (QoQ) | +46.86% |
| Owned by Insiders (%) | 68.81% |
| Owned by Institutions (%) | n/a |
| Float | 3.68M |
Valuation Ratios
The trailing PE ratio is 23.80.
| PE Ratio | 23.80 |
| Forward PE | n/a |
| PS Ratio | 0.90 |
| PB Ratio | 1.68 |
| P/TBV Ratio | 1.84 |
| P/FCF Ratio | 401.19 |
| P/OCF Ratio | 60.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.24, with an EV/FCF ratio of 405.94.
| EV / Earnings | 23.72 |
| EV / Sales | 0.92 |
| EV / EBITDA | 16.24 |
| EV / EBIT | 16.89 |
| EV / FCF | 405.94 |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.14 |
| Quick Ratio | 1.33 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.42 |
| Debt / FCF | 10.57 |
| Interest Coverage | 36.65 |
Financial Efficiency
Return on equity (ROE) is 10.76% and return on invested capital (ROIC) is 8.27%.
| Return on Equity (ROE) | 10.76% |
| Return on Assets (ROA) | 5.34% |
| Return on Invested Capital (ROIC) | 8.27% |
| Return on Capital Employed (ROCE) | 8.95% |
| Weighted Average Cost of Capital (WACC) | 6.18% |
| Revenue Per Employee | 154.89M |
| Profits Per Employee | 5.98M |
| Employee Count | 69 |
| Asset Turnover | 1.58 |
| Inventory Turnover | 10.52 |
Taxes
In the past 12 months, NSE:REMUS has paid 137.90 million in taxes.
| Income Tax | 137.90M |
| Effective Tax Rate | 21.88% |
Stock Price Statistics
The stock price has increased by +2.11% in the last 52 weeks. The beta is 0.36, so NSE:REMUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +2.11% |
| 50-Day Moving Average | 902.22 |
| 200-Day Moving Average | 767.73 |
| Relative Strength Index (RSI) | 42.68 |
| Average Volume (20 Days) | 6,140 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:REMUS had revenue of INR 10.69 billion and earned 412.50 million in profits. Earnings per share was 33.78.
| Revenue | 10.69B |
| Gross Profit | 1.22B |
| Operating Income | 579.10M |
| Pretax Income | 630.20M |
| Net Income | 412.50M |
| EBITDA | 602.40M |
| EBIT | 579.10M |
| Earnings Per Share (EPS) | 33.78 |
Balance Sheet
The company has 553.70 million in cash and 254.80 million in debt, with a net cash position of 298.90 million or 25.36 per share.
| Cash & Cash Equivalents | 553.70M |
| Total Debt | 254.80M |
| Net Cash | 298.90M |
| Net Cash Per Share | 25.36 |
| Equity (Book Value) | 5.77B |
| Book Value Per Share | 515.10 |
| Working Capital | 1.61B |
Cash Flow
In the last 12 months, operating cash flow was 159.80 million and capital expenditures -135.70 million, giving a free cash flow of 24.10 million.
| Operating Cash Flow | 159.80M |
| Capital Expenditures | -135.70M |
| Depreciation & Amortization | 23.30M |
| Net Borrowing | 98.40M |
| Free Cash Flow | 24.10M |
| FCF Per Share | 2.05 |
Margins
Gross margin is 11.37%, with operating and profit margins of 5.42% and 3.86%.
| Gross Margin | 11.37% |
| Operating Margin | 5.42% |
| Pretax Margin | 5.90% |
| Profit Margin | 3.86% |
| EBITDA Margin | 5.64% |
| EBIT Margin | 5.42% |
| FCF Margin | 0.23% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.12%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.12% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3.01% |
| FCF Payout Ratio | 73.34% |
| Buyback Yield | 0.27% |
| Shareholder Yield | 0.39% |
| Earnings Yield | 4.20% |
| FCF Yield | 0.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on July 4, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jul 4, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |